BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26252430)

  • 21. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
    Lai HY; Chou TY; Tzeng CH; Lee OK
    Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
    Zhao XY; Xu LL; Lu SY; Huang XJ
    Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Hildebrandt GC; Choi SW; Mueller G; Olkiewicz KM; Moore BB; Cooke KR
    Pediatr Blood Cancer; 2008 Apr; 50(4):911-4. PubMed ID: 17455319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
    Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
    Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
    Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
    Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine protects mice from acute graft-versus-host disease (aGVHD).
    Song EK; Yim JM; Yim JY; Song MY; Rho HW; Yim SK; Han YH; Jeon SY; Kim HS; Yhim HY; Lee NR; Kwak JY; Sohn MH; Park HS; Jang KY; Yim CY
    Biochem Biophys Res Commun; 2013 May; 435(1):94-9. PubMed ID: 23624505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
    Wang CL; Xu KL; Pan XY; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance.
    Chen W; Su G; Xu Y; Guo W; Bhansali R; Pan B; Kong Q; Cheng H; Cao J; Qi K; Zhu F; Li M; Zhu S; Zeng L; Li Z; Wu Q; Xu K
    Int Immunopharmacol; 2021 May; 94():107503. PubMed ID: 33647825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
    Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    Williamson E; Garside P; Bradley JA; More IA; Mowat AM
    J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model.
    Nakauchi Y; Yamazaki S; Napier SC; Usui J; Ota Y; Takahashi S; Watanabe N; Nakauchi H
    Exp Hematol; 2015 Feb; 43(2):79-88.e1-4. PubMed ID: 25448490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell.
    Zhao K; Zhao D; Huang D; Yin L; Chen C; Pan B; Wu Q; Li Z; Yao Y; Shen E; Zeng L; Xu K
    J Interferon Cytokine Res; 2014 Sep; 34(9):707-15. PubMed ID: 24720737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.
    Hatano R; Itoh T; Otsuka H; Saeki H; Yamamoto A; Song D; Shirakawa Y; Iyama S; Sato T; Iwao N; Harada N; Aune TM; Dang NH; Kaneko Y; Yamada T; Morimoto C; Ohnuma K
    Am J Transplant; 2022 Dec; 22(12):2804-2820. PubMed ID: 35997569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease.
    Marillier RG; Uyttenhove C; Goriely S; Marbaix E; Van Snick J
    Eur J Immunol; 2014 Jul; 44(7):2064-73. PubMed ID: 24700119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.